<< Back to News

System Formulary Update
Pafolacianine (Cytalux)

Situation

Pafolacianine 3.2 mg/1.6 mL injection solution was approved for addition to the health system formulary at the March 2022 System Pharmacy and Therapeutics Committee meeting.

Background

The following medication was reviewed: Pafolacianine 3.2 mg/1.6 mL injection solution

Assessment/Recommendations

System P&T voted to include the following products on the UNC Health Medication Formulary:

• Pafolacianine 3.2 mg/1.6 mL injection solution

Note: Stock of this formulary product may vary at individual entities

Formulary/Epic changes will Go-Live on Tuesday, September 27, 2022.